BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND LIFR, SJS2, 3977, ENSG00000113594, SWS, STWS, CD118
31 results:

  • 1. Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma.
    de Miguel-Perez D; Pickering EM; Malapelle U; Grier W; Pepe F; Pisapia P; Russo G; Pinto JA; Russo A; Troncone G; Culligan MJ; Scilla KA; Mehra R; Mohindra P; Arrieta O; Cardona AF; Del Re M; Sachdeva A; Hirsch FR; Wolf A; Friedberg JS; Rolfo C
    Eur J Cancer; 2024 Jan; 196():113457. PubMed ID: 38008032
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comprehensive analysis of the lncRNAs-related immune gene signatures and their correlation with immunotherapy in lung adenocarcinoma.
    Yang Z; Zhu J; Yang T; Tang W; Zheng X; Ji S; Ren Z; Lu F
    Br J Cancer; 2023 Oct; 129(9):1397-1408. PubMed ID: 37543671
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Role and mechanism of leukemia inhibitory factor receptor in cervical cancer invasion and metastasis.
    Hu H; Zhao Q; Sang Y; Xiao Y; Jiang N
    J Int Med Res; 2023 Jun; 51(6):3000605231182557. PubMed ID: 37357760
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification and integration analysis of a novel prognostic signature associated with cuproptosis-related ferroptosis genes and relevant lncRNA regulatory axis in lung adenocarcinoma.
    Wang T; Jiang X; Lu Y; Ruan Y; Wang J
    Aging (Albany NY); 2023 Mar; 15(5):1543-1563. PubMed ID: 36881404
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic cancer and lung cancer.
    Liu S; Gandler HI; Tošić I; Ye DQ; Giaccone ZT; Frank DA
    Mol Cancer Res; 2021 Aug; 19(8):1283-1295. PubMed ID: 33931487
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Hsa_circ_0001073 targets miR-626/lifr axis to inhibit lung cancer progression.
    Liu Q; Cao G; Wan Y; Xu C; He Y; Li G
    Environ Toxicol; 2021 Jun; 36(6):1052-1060. PubMed ID: 33475233
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis.
    Lin WH; Chang YW; Hong MX; Hsu TC; Lee KC; Lin C; Lee JL
    Oncogene; 2021 Jan; 40(4):791-805. PubMed ID: 33262462
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Engineering a potent receptor superagonist or antagonist from a novel IL-6 family cytokine ligand.
    Kim JW; Marquez CP; Sperberg RAP; Wu J; Bae WG; Huang PS; Sweet-Cordero EA; Cochran JR
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14110-14118. PubMed ID: 32522868
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pulmonary nodular and cystic light chain deposition disease: A retrospective review of 10 cases.
    Baqir M; Moua T; White D; Yi ES; Ryu JH
    Respir Med; 2020 Apr; 164():105896. PubMed ID: 32217287
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Phosphorylation of lifr promotes prostate cancer progression by activating the AKT pathway.
    Shao J; Zhu W; Ding Y; Zhu H; Jing X; Yu H; Lu M; Qiao Y; Wang X; Ai H; Wang X
    Cancer Lett; 2019 Jun; 451():110-121. PubMed ID: 30851421
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. miR-589 promotes gastric cancer aggressiveness by a lifr-PI3K/AKT-c-Jun regulatory feedback loop.
    Zhang F; Li K; Pan M; Li W; Wu J; Li M; Zhao L; Wang H
    J Exp Clin Cancer Res; 2018 Jul; 37(1):152. PubMed ID: 30012200
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Does timeliness of care in Non-Small Cell lung cancer impact on survival?
    Vinod SK; Chandra A; Berthelsen A; Descallar J
    Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
    Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
    Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. XRCC3 T241M polymorphism and lung cancer risk in the Han Chinese population: a meta-analysis.
    Zhang JH; Wen QL; Yang C; Li AL; Liu Y; Li XS
    Genet Mol Res; 2014 Nov; 13(4):9505-13. PubMed ID: 25501160
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data.
    Tan X; Chen M
    Tumour Biol; 2014 Dec; 35(12):12189-200. PubMed ID: 25179839
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma.
    Cheng Y; Cheung AK; Ko JM; Phoon YP; Chiu PM; Lo PH; Waterman ML; Lung ML
    BMC Cell Biol; 2013 Sep; 14():44. PubMed ID: 24073846
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Hyponatremia in cancer patients].
    Matsuura T
    Nihon Jinzo Gakkai Shi; 2012; 54(7):1016-22. PubMed ID: 23234213
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Do multidisciplinary team meetings make a difference in the management of lung cancer?
    Boxer MM; Vinod SK; Shafiq J; Duggan KJ
    Cancer; 2011 Nov; 117(22):5112-20. PubMed ID: 21523766
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Study of use of pemetrexed in non-small cell lung cancer].
    Villanueva-Herraiz S; Ortega-García MP; Camps-Herrero C; Blasco-Segura P
    Farm Hosp; 2010; 34(4):194-203. PubMed ID: 20594885
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.
    Gandhi J; Zhang J; Xie Y; Soh J; Shigematsu H; Zhang W; Yamamoto H; Peyton M; Girard L; Lockwood WW; Lam WL; Varella-Garcia M; Minna JD; Gazdar AF
    PLoS One; 2009; 4(2):e4576. PubMed ID: 19238210
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.